Clinical trials: Intraosseous Vascular Access
Intraosseous Access, Infusion Rates
Infusion Flow Rates and Blood Sampling
To evaluate infusion flow rates attainable when using the proximal humerus and proximal tibia IO vascular access sites. To evaluate the intraosseous infusion physiology when using the proximal humerus and proximal tibia IO…
- Conditions
- Intraosseous Access, Infusion Rates, Intraosseous Blood, Venous Blood
- Trial name
- NCT02021617
- Testing
- Intraosseous access
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Vidacare Corporation
Intraosseous Vascular Access
Proximal Humerus Site for Anesthesia
This will be a prospective, non-controlled study using healthy adult volunteers as subjects receiving bilateral proximal humerus intraosseous (IO) vascular access to evaluate the insertion technique and IO infusion flow rates.
- Trial name
- NCT01866514
- Testing
- intraosseous vascular access in the proximal humerus, EZ-IO
- Where
- United States
- Volunteers
- 5 people, healthy volunteers welcome
- Sponsor
- Vidacare Corporation
Intraosseous Vascular Access
Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum
This study is being done to evaluate intraosseous vascular access through the sternum.
- Trial name
- NCT01853215
- Testing
- T.A.L.O.N. Intraosseous System
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Vidacare Corporation
Vascular Access
Evaluation of Various Methods Used to Identify the Proximal Humerus Intraosseous Vascular Access Site
The purpose of this study is to determine if there is one method of identifying the proximal humerus intraosseous vascular access site that is easier for clinicians to use, out of the 4 methods being evaluated.
- Trial name
- NCT01742780
- Testing
- Intraosseous Vascular Access
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Vidacare Corporation
Intraosseous Vascular Access
Continuous Intraosseous Vascular Access Over 48 Hours
A prospective study to determine the safety of intraosseous (IO) access for a period up to 48 hours in healthy adult volunteers and volunteers with a history of mild to moderate renal disease and/or controlled diabetes.
- Trial name
- NCT01866475
- Testing
- EZ-IO
- Where
- United States
- Volunteers
- 127 people, healthy volunteers welcome
- Sponsor
- Vidacare Corporation
Intraosseous Vascular Access, Vascular Access
Follow-Up Study Validating a Blended Technique to Identify the Proximal Humerus Intraosseous Vascular Access Site
A Follow-up Study Validating a Blended Technique for Identifying the Proximal Humerus Intraosseous Vascular Access Insertion Site
- Trial name
- NCT01866501
- Testing
- Intraosseous Vascular Access
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Vidacare Corporation